ArticleDiscover oncology2025

Ubiquitin-specific protease 34 serves as a novel prognostic biomarker through correlating with immune responses and cell proliferation in acute myeloid leukemia.

Zhihui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.